Family of 8-year-old with melanoma calls on all Australians to step up to help save lives

Family of 8-year-old with melanoma calls on all Australians to step up to help save lives

26 March 2021

Little Hayden Price was just 7-years-old when his parents noticed what they thought was an irritated skin tag on the back of his scalp. The adventurous school boy, who loves swimming and playing with his two older brothers Harry (10) and Hugh (11), began complaining that his goggles and hats were rubbing a sore spot on the back of his head.

His parents Liza and Nathan were shocked when a trip to the GP in Singapore, where they live as part of the Australian expat community, revealed the spot was in fact a melanoma.
Little Hayden underwent surgery to remove the melanoma early last July, just one day after his 8th birthday.

‘We just didn’t think that children as young as Hayden could get melanoma,’ said his mum Liza. ‘It just never crossed our minds that a cancer diagnosis was even possible. Hayden has never been sunburnt in his entire life so we were absolutely stunned and devastated.’

Melanoma Institute Australia (MIA) Co-Medical Director, Professor Richard Scolyer, who is the world’s leading melanoma pathologist, confirmed the difficult diagnosis. He said whilst melanoma is rare in young children, it does happen, and in Hayden’s case, his melanoma is a sub-type not related to sun exposure.

‘It is a dangerous misconception that melanoma is just an older person’s disease that occurs after decades of sun exposure,’ Professor Scolyer said. ‘Melanoma is in fact the most common cancer in 15 to 39 year old Australians, and whilst rare, we do also see a handful of cases each year in younger children.’

With Hayden’s melanoma already having spread to his lymph nodes, his case was referred to MIA Co-Medical Director and medical oncologist, Professor Georgina Long AO. Professor Long presented Hayden’s case at MIA’s weekly Multi-Disciplinary Team meeting where a cohort of leading clinicians brainstorm and discuss complex cases. A treatment plan was then agreed on with Hayden’s treating oncologist in Singapore.

‘Hayden was immediately started on immunotherapy, a breakthrough treatment which harnesses the body’s own immune system to fight the cancer cells,’ Professor Long said. ‘Had Hayden been born less than a decade earlier, this treatment would not have been available.’

Hayden has so far had 11 infusions of immunotherapy, and has six more to go. His family hopes he will be one of the lucky ones who responds to the treatment. They are anxiously awaiting results of follow up scans to see if the melanoma cells in his little body have been halted, slowed or killed.

‘We feel extremely fortunate that we have amazing specialists treating Hayden, combined with the availability of immunotherapy which was not available prior to 2017,’ Liza said. ‘This gives us tremendous hope for the future.’

The Price family, originally from Brisbane and Lismore, has decided to speak out and share their heartbreaking story to inspire Australians to rally and support research into new melanoma treatments, like the one they are confident will save Hayden’s life.

‘It was a difficult decision to go public with our story as we are in the middle of it, however we wanted to share this important message,’ Hayden’s dad Nathan said. ‘If you have doubts about changes in your child’s skin, including moles, bumps or lesions, please have them checked by a specialist, even in young kids.
‘Research into melanoma is changing lives for many families including ours, so please contribute by purchasing digital footprints supporting the Melanoma March campaign, if you can.’

MIA’s annual fundraising campaign, Melanoma March, is needing to raise $500,000 to support ongoing research focussing on the 50% of advanced melanoma patients who don’t respond to these new treatments. The traditional physical march events were unable to go ahead due to COVID, and were replaced with a digital campaign where people are asked to buy $30 digital footprints which they personalise with messages of hope or support. So far, $150,000 has been raised, leaving a further $350,000 to be raised to meet the target.

Australia has the highest melanoma rates in the world with one person diagnosed every 30 minutes. 1,300 Australians are expected to die from the disease this year.

‘Our story is proof that melanoma can and does impact anyone, regardless of age, and it is up to all of us to help support our research teams who are leading global efforts to save lives from this disease,’ Liza added.
‘That’s why we have decided to share our story, so that some good may possibly come from the difficult journey that Hayden and our family are now on.

MIA's Melanoma March campaign has now finished. You can still step up for Hayden by making a donation to support melanoma research here, or hold an Odd Sock Day! 

Odd Sock Day  

Inspired by Hayden and his love of odd socks, the Australian International School in Singapore held an Odd Sock Day to raise funds for melanoma research. Australian schools and workplaces are urged to join them. All Odd Sock Day donations support melanoma research. Please email Annabel at fundraise@melanoma.org.au for more details.  

 

Hayden's Story on 9News 

 

MEDIA - For more information, please contact:
Jennifer Durante |Melanoma Institute Australia | 0412 798 990 | jennifer.durante@melanoma.org.au

Q&A with our Clinical Research Fellow
26 May 2015

Q&A with our Clinical Research Fellow

We sat down for a short Q&A with our Clinical Research Fellow Sangeetha Ramanujam

International Clinical Trials Day marked
20 May 2015

International Clinical Trials Day marked

Today marks International Clinical Trials Day held on May 20 each year celebrating how far clinicians have come in the field of research. 

5 minutes with Practice Manager Sherrie D'Souza
15 May 2015

5 minutes with Practice Manager Sherrie D'Souza

We sat down with MIA Practice Manager, Sherrie D'Souza and got an insight into the day of life of her role. 

Associate Professor Georgina Long has won the InStyle Women In Style Award
14 May 2015

Associate Professor Georgina Long has won the InStyle Women In Style Award

Dr Long was nomitated for the InStyle Women In Style Awards in the Science and Environment category. 

The Federal Government's 2015-16 Budget announcements benefit research
14 May 2015

The Federal Government's 2015-16 Budget announcements benefit research

The Federal Government’s 2015-16 Budget was announced this week with a boost for medical research funding. 

Professor Thompson made an honorary member of the American Surgical Association
01 May 2015

Professor Thompson made an honorary member of the American Surgical Association

The Association's members include prominent surgeons from around the world. 

MIA leads the world-first study that finds anti–PD-1 antibody pembrolizumab increases the survival of patients
20 Apr 2015

MIA leads the world-first study that finds anti–PD-1 antibody pembrolizumab increases the survival of patients

This is a landmark study, the first in a class of drugs that will change the future of treatment for all cancers. 

Anti-PD1 immunotherapy pembrolizumab (KEYTRUDA®) has been registered by the TGA
20 Apr 2015

Anti-PD1 immunotherapy pembrolizumab (KEYTRUDA® ) has been registered by the TGA

Australia is the first country in the world to register anti-PD1 for the first line treatment of unresectable or metastatic melanoma in adults.

MIA's Autumn Newsletter
12 Apr 2015

MIA's Autumn Newsletter

Our Autumn newsletter has been published and we have our digital version online now. 

Professor John Thompson appointed to Australian Academy of Health and Medical Sciences
31 Mar 2015

Professor John Thompson appointed to Australian Academy of Health and Medical Sciences

Professor John Thompson, Executive Director at Melanoma Institute Australia, was one of 116 fellows appointed to the new Australian Academy of Health and Medical Sciences at a ceremony in Canberra on the 25th March.

Melanoma Institute part of $14m melanoma project grant
25 Mar 2015

Melanoma Institute part of $14m melanoma project grant

Federal Minister for Health, the Hon. Sussan Ley, announced more than $14 million in funding for a research program to study the molecular determinants of risk, progression and treatment response in melanoma.

Melanoma March Bibs
19 Mar 2015

Melanoma March Bibs

If you would like to download a bib for your Melanoma March, we have a selection for you to choose from, print and bring along with you on the day. 

Manly Melanoma March
17 Mar 2015

Manly Melanoma March

Manly Melanoma March has changed to a new location. 

Q&A with Melanoma March Fundraisers
10 Mar 2015

Q&A with Melanoma March Fundraisers

We did a short Q&A with two sisters who are raising funds for Melanoma March after sadly losing their mother in 2009. This is their second march and they have shared with us their fundraising tips. 

Research Director Graham Mann explains where Melanoma March funds are going
10 Mar 2015

Research Director Graham Mann explains where Melanoma March funds are going

We want to share with you what your valuable Melanoma March donation and fundraising goes towards and our Research Director, Graham Mann explains the national research project the funds will be going towards.

First patient recruited to the EAGLE FM Trial
09 Mar 2015

First patient recruited to the EAGLE FM Trial

Evaluation of Groin Lymphadenectomy Extent for Metastatic Melanoma (EAGLE FM) clinical trial has recruited its first patient.  

Online Comments to the Pharmaceutical Benefits Advisory Committee
09 Feb 2015

Online Comments to the Pharmaceutical Benefits Advisory Committee

You are invited to provide comments for consideration by the Pharmaceutical Benefits Advisory Committee (PBAC). The PBAC will consider the registration of the anti-PD1 drug, Keytruda (pembrolizumab) at the next meeting in March.

A man of commitment
06 Feb 2015

A man of commitment

Melanoma patient Joel Allsop was congratulated today on completing his participation in the international surgical clinical trial, known as MSLT-II. He was the first person in the world to complete the 10 years of follow-up for this trial. 

Melanoma March has officially launched
05 Feb 2015

Melanoma March has officially launched

Melanoma Institute Australia (MIA) has officially launched the 2015 ‘Melanoma March’ initiative in Melbourne.